Sencell -
Driven by Nature

Our Sencell sensor technology will provide real time, long term, accurate glucose readings straight to your smart device. Lifecare is dedicated to develop the next generation of glucose sensors.

Based on the osmotic pressure readings in your body, Sencell is driven by nature.

Take control of
your blood sugar

The osmotic sensor is an implantable 3D printed nano-sensor for subcutaneous location, minimum 6 months usage time, wireless, continuous, read out unit real time glucose measurement for diabetes management. The Sencell glucose monitoring system includes an osmotic pressure sensor (sensor core), transmitter (sensor electronics) and a mobile medical application (reader) to continuously measure glucose in the interstitial fluid.

Inject and forget

No pricking or unpractical transmitters. The Sencell micro sensor will be injected under the skin on your wrist and operate independently to provide you with continuous glycemic information.

Convenient and simple in use

The sensor requires very little operating energy to transfer real time glucose data wirelessly from the sensor to your smart device. The sensor is self-sustained with energy. Therefor you can read the glucose data as often as you want on your smart device.

Maintain control

The wireless, real time data transfer, with alarm functions of the Sencell, will help you maintaining glucose levels within threshold, and continuously warn you and nest of kin of high and low glucose levels.

Attributes

Between 1980 and 2017, the number of people with type 1 and type 2 diabetes worldwide has more than doubled reaching 425 million people worldwide and is projected to rise to 629 million by 2045 (Intl Diabetes Fed. As of today their lives are dependent on a 40+ year old technology. people with diabetes deserve something better. They deserve a modern tool such as Sencell.

Benefits

5 million people die every year due to poorly managed glucose levels. Uncontrolled diabetes can lead to serious health complications such as heart disease, stroke, blindness, amputation, nephropathy and cardiac failure, and this just to name a few.

More effective methods which can detect, monitor and control this disease, require development of new tools. The Sencell will provide people with diabetes functions far beyond from what present day products and technology does.

Inject and forget

No pricking or unpractical transmitters. The Sencell micro sensor will be injected under the skin on your wrist and operate independently to provide you with continuous glycemic information.

Convenient and simple in use

Read the glucose data as often as you want on your smart device.

Control

The wireless, real time data transfer, with alarm functions of the Sencell, shall warn you of high and low glucose levels.

Low cost

In order to help as many people as possible, the Sencell will be designed to maintain operating costs significantly lower than other comparable devices.

No body worn devices

The complete sensor device is very convenient in use. The sensor is 100% fully implantable and implies that there are no body worn devices, therefor the sensor operates unobtrusively.

Science and technology

The Sencell is small, complex, self-sustained implantable sensor which is designed to continuously monitor your glucose.

The osmotic sensor is an implantable 3D printed nano-sensor for subcutaneous location, minimum 6 months usage time, wireless, continuous, read out unit real time glucose measurement for diabetes management.

The main objective of the Sencell Implantable Miniaturized Osmotic Sensor Device is to provide a convenient, efficient, reliable, painless, accurate and durable continuous glucose measurement (CGM) solution at a low cost for daily use to people with diabetes. The unique and advanced technology of Sencell offers a novel and disruptive technology for the global market.

The Sencell glucose monitoring system includes an osmotic pressure sensor (sensor core), transmitter (sensor electronics) and a mobile medical application (reader) to continuously measure glucose in the interstitial fluid.

In order to help as many people as possible, the Sencell will be designed to maintThe sensor device will be further miniaturized to meet the anticipated final size specifications, to become implantable with a simple insertion procedure and to improve performance with respect to accuracy, sensitivity, stability and robustness. A second source for both the glucose and the pressure information will be introduced by a cantilever nanoscale 3D printed technology.ain operating costs significantly lower than other comparable devices.

The cantilever based glucose sensor will be used as a reference glucose sensor recalibrating signal drift in the osmotic pressure sensor approach. The sensor (with dimensions in the µm scale) will be implemented on the surface of the osmotic chamber with direct access to the interstitial fluid. The overall size of the two cantilevers is about 500 µm in substrate length and1 mm in substrate width. The cantilevers are about 50×50 µm² (length × width) and feature a thickness of 100 nm to 300 nm. These small dimensions allow easy incorporation of the cantilever array in the existing Sencellimplant designs. Additionally, the cantilevers’ small dimensions enable a high sensitivity.

The proposed use of the nano3DSense™-technology allows for a high degree of pressure transducer miniaturization and enables to easily incorporate even a second pressure transducer allowing to measure changes in external pressure (pressure reference). The strain sensors are directly 3D-printed onto the membrane with the nano3DSense™-printing technology. In this way, the transducer membrane can be made of any material, including biocompatible metals (e.g. titanium).

Presentations

Lifecare Scientific presentation

Winter 2020

Lifecare Scientific presentation

Winter 2018

Sencell | A novel implantable 3D printed nanosensor

For a long-tem continous glucose measurement

Long term miniaturisation pressure chamber using 3D nano-printing technology

Long term miniaturisation pressure chamber using 3D nano-printing technology

The planned Sencell dimensions are 2x3x6 mm3